resiquimod has been researched along with lysine in 2 studies
| Studies (resiquimod) | Trials (resiquimod) | Recent Studies (post-2010) (resiquimod) | Studies (lysine) | Trials (lysine) | Recent Studies (post-2010) (lysine) |
|---|---|---|---|---|---|
| 465 | 14 | 318 | 37,449 | 622 | 11,213 |
| Protein | Taxonomy | resiquimod (IC50) | lysine (IC50) |
|---|---|---|---|
| Cationic amino acid transporter 3 | Homo sapiens (human) | 158 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Chiang, IH; Chuang, YT; Hsieh, WC; Hsu, SC; Lai, MZ; Miaw, SC | 1 |
2 other study(ies) available for resiquimod and lysine
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Inability to resolve specific infection generates innate immunodeficiency syndrome in Xiap-/- mice.
Topics: Adaptor Proteins, Signal Transducing; Animals; B-Cell CLL-Lymphoma 10 Protein; beta-Glucans; Candida albicans; Candidiasis; ErbB Receptors; Genetic Diseases, X-Linked; Humans; Imidazoles; Immunity, Innate; Inhibitor of Apoptosis Proteins; Lectins, C-Type; Lipopeptides; Lipopolysaccharides; Lymphoproliferative Disorders; Lysine; Lysophospholipids; Macrophages; Mice; NF-kappa B; Phagocytosis; Poly I-C; Protein Binding; Receptors, Antigen, T-Cell; Toll-Like Receptors; Tumor Necrosis Factor-alpha; Ubiquitination | 2014 |